McKesson Co. (NYSE:MCK – Get Rating) EVP Nancy Avila sold 1,330 shares of the firm’s stock in a transaction dated Tuesday, May 30th. The stock was sold at an average price of $383.89, for a total transaction of $510,573.70. Following the completion of the transaction, the executive vice president now owns 10,390 shares of the company’s stock, valued at $3,988,617.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Nancy Avila also recently made the following trade(s):
- On Friday, May 26th, Nancy Avila sold 491 shares of McKesson stock. The stock was sold at an average price of $394.38, for a total transaction of $193,640.58.
McKesson Stock Performance
Shares of MCK opened at $389.23 on Friday. The firm has a market cap of $52.78 billion, a PE ratio of 15.50, a PEG ratio of 1.34 and a beta of 0.58. The firm’s 50 day moving average price is $372.55 and its 200 day moving average price is $369.38. McKesson Co. has a twelve month low of $298.69 and a twelve month high of $401.78.
McKesson Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, July 3rd. Stockholders of record on Thursday, June 1st will be given a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 0.55%. The ex-dividend date is Wednesday, May 31st. McKesson’s dividend payout ratio is 8.60%.
Analysts Set New Price Targets
MCK has been the subject of several recent analyst reports. Morgan Stanley raised their target price on shares of McKesson from $420.00 to $426.00 and gave the stock an “overweight” rating in a report on Thursday, February 2nd. Mizuho raised their target price on shares of McKesson from $376.00 to $390.00 in a report on Tuesday, May 9th. 58.com reissued a “maintains” rating on shares of McKesson in a research report on Tuesday, May 9th. Robert W. Baird increased their price target on shares of McKesson from $450.00 to $475.00 in a research report on Tuesday, May 9th. Finally, StockNews.com assumed coverage on shares of McKesson in a research report on Thursday, May 18th. They issued a “strong-buy” rating for the company. Two analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $430.17.
Hedge Funds Weigh In On McKesson
Institutional investors have recently modified their holdings of the company. Live Oak Investment Partners bought a new position in shares of McKesson in the fourth quarter valued at approximately $30,000. Column Capital Advisors LLC grew its stake in shares of McKesson by 189.3% in the fourth quarter. Column Capital Advisors LLC now owns 81 shares of the company’s stock worth $30,000 after acquiring an additional 53 shares during the last quarter. Covestor Ltd grew its stake in shares of McKesson by 72.3% in the first quarter. Covestor Ltd now owns 81 shares of the company’s stock worth $25,000 after acquiring an additional 34 shares during the last quarter. Carmel Capital Partners LLC acquired a new stake in shares of McKesson in the first quarter worth $30,000. Finally, Machina Capital S.A.S. acquired a new stake in shares of McKesson in the first quarter worth $33,000. Institutional investors own 85.23% of the company’s stock.
About McKesson
McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS).
Featured Articles
- Get a free copy of the StockNews.com research report on McKesson (MCK)
- Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
- Nordstrom’s Earnings Beat, A Rally In The Making
- What is the Penalty for Excess Contributions to an IRA?
- How to Invest in Specialty Retail Stores
- Unlocking Potential: Comparing IRA vs. CD vs. Money Market Accounts
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.